ClinicalTrials.govpublic full text
Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking
nicotine dependence, drugs, investigational, therapies for relapse to nicotine, relapse prevention, nicotine cessation therapies, smoking cessation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 894044
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.